Source: The Business Journals: Philadelphia

Artfire: Former Harmony CEO John Jacobs reshaping D.C. biotech with multibillion-dollar Sanofi deal

John Jacobs left Plymouth Meeting's Harmony Biosciences in 2023 after overseeing its IPO.

Read full article »
Artfire's Competitors | Artfire's News | Artfire's Financials
Stay up-to-date with the latest news on Artfire
Est. Annual Revenue
$5.0-25M
Est. Employees
1-25
John A. Jacobs's photo - Founder & CEO of Artfire

Founder & CEO

John A. Jacobs

CEO Approval Rating

82/100

Read more
Stay up-to-date with the latest news on Artfire